{"protocolSection":{"identificationModule":{"nctId":"NCT00130338","orgStudyIdInfo":{"id":"CENA713BIA05E1"},"organization":{"fullName":"Novartis","class":"INDUSTRY"},"briefTitle":"Rivastigmine Capsules in Patients With Probable Vascular Dementia","officialTitle":"An Open-label Extension to Evaluate the Efficacy and Safety of Rivastigmine Capsules in Patients With Probable Vascular Dementia"},"statusModule":{"statusVerifiedDate":"2017-03","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2002-02"},"primaryCompletionDateStruct":{"date":"2006-05","type":"ACTUAL"},"completionDateStruct":{"date":"2006-05","type":"ACTUAL"},"studyFirstSubmitDate":"2005-08-11","studyFirstSubmitQcDate":"2005-08-11","studyFirstPostDateStruct":{"date":"2005-08-15","type":"ESTIMATED"},"lastUpdateSubmitDate":"2017-03-24","lastUpdatePostDateStruct":{"date":"2017-03-28","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Novartis","class":"INDUSTRY"}},"descriptionModule":{"briefSummary":"The goal of this research study is to evaluate, in the open-label extension phase, the effectiveness, tolerability and safety of rivastigmine capsules in males and females between the ages of 50 and 85 years old with probable vascular dementia."},"conditionsModule":{"conditions":["Vascular Dementia"],"keywords":["Dementia","Vascular","Rivastigmine","Stroke","Memory loss"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE3"],"designInfo":{"allocation":"NON_RANDOMIZED","interventionModel":"SINGLE_GROUP","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":521,"type":"ACTUAL"}},"armsInterventionsModule":{"interventions":[{"type":"DRUG","name":"Rivastigmine"}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Safety and tolerability of rivastigmine for up to 52 weeks of treatment in patients with VaD and probable VaD"}],"secondaryOutcomes":[{"measure":"52 week's treatment with rivastigmine on cognition, activities of daily living, behavior and clinical staging in patients with VaD and probable VaD"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patients who complete the double-blind treatment phase or those who have dropped out early in the study, but have returned for all the remaining scheduled efficacy assessments (retrieved drop-out patients) without significant protocol violations are eligible to participate.\n\nExclusion Criteria:\n\n* Retrieved drop-out patients, who have been treated with other cholinergic drugs during the past 4 weeks","healthyVolunteers":false,"sex":"ALL","minimumAge":"50 Years","maximumAge":"85 Years","stdAges":["ADULT","OLDER_ADULT"]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000003704","term":"Dementia"},{"id":"D000015140","term":"Dementia, Vascular"}],"ancestors":[{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000019965","term":"Neurocognitive Disorders"},{"id":"D000001523","term":"Mental Disorders"},{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000002537","term":"Intracranial Arteriosclerosis"},{"id":"D000020765","term":"Intracranial Arterial Diseases"},{"id":"D000056784","term":"Leukoencephalopathies"},{"id":"D000001161","term":"Arteriosclerosis"},{"id":"D000001157","term":"Arterial Occlusive Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M6594","name":"Dementia","asFound":"Dementia","relevance":"HIGH"},{"id":"M17551","name":"Dementia, Vascular","asFound":"Vascular Dementia","relevance":"HIGH"},{"id":"M3675","name":"Amnesia","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M21526","name":"Neurocognitive Disorders","relevance":"LOW"},{"id":"M4505","name":"Mental Disorders","relevance":"LOW"},{"id":"M14163","name":"Psychotic Disorders","relevance":"LOW"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M5476","name":"Intracranial Arteriosclerosis","relevance":"LOW"},{"id":"M4159","name":"Arteriosclerosis","relevance":"LOW"},{"id":"M22211","name":"Intracranial Arterial Diseases","relevance":"LOW"},{"id":"M28281","name":"Leukoencephalopathies","relevance":"LOW"},{"id":"M4155","name":"Arterial Occlusive Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BXM","name":"Behaviors and Mental Disorders"},{"abbrev":"BC23","name":"Symptoms and General Pathology"}]},"interventionBrowseModule":{"meshes":[{"id":"D000068836","term":"Rivastigmine"}],"ancestors":[{"id":"D000002800","term":"Cholinesterase Inhibitors"},{"id":"D000004791","term":"Enzyme Inhibitors"},{"id":"D000045504","term":"Molecular Mechanisms of Pharmacological Action"},{"id":"D000018678","term":"Cholinergic Agents"},{"id":"D000018377","term":"Neurotransmitter Agents"},{"id":"D000045505","term":"Physiological Effects of Drugs"},{"id":"D000018696","term":"Neuroprotective Agents"},{"id":"D000020011","term":"Protective Agents"}],"browseLeaves":[{"id":"M317","name":"Rivastigmine","asFound":"Nasopharyngeal Carcinoma","relevance":"HIGH"},{"id":"M5730","name":"Cholinesterase Inhibitors","relevance":"LOW"},{"id":"M7641","name":"Enzyme Inhibitors","relevance":"LOW"},{"id":"M20448","name":"Cholinergic Agents","relevance":"LOW"},{"id":"M20194","name":"Neurotransmitter Agents","relevance":"LOW"},{"id":"M20463","name":"Neuroprotective Agents","relevance":"LOW"},{"id":"M21559","name":"Protective Agents","relevance":"LOW"}],"browseBranches":[{"abbrev":"NeuroAg","name":"Neuroprotective Agents"},{"abbrev":"All","name":"All Drugs and Chemicals"}]}},"hasResults":false}